Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study. 2017

K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
CHUM Research Center, 900, St-Denis street, Viger Tower, Montreal, Quebec H2X 0A9, Canada; Department of Psychiatry, Université de Montréal, C.P. 6128, succursale Centre-ville, Montreal, Québec H3C 3J7, Canada.

Cannabis consumption is common among cocaine users; however, little is known about its effect on cocaine craving. The objective of this study was to assess whether cannabis co-use is associated with lower cue-induced cocaine craving in non-treatment-seeking cocaine-dependent individuals. Data from twenty-eight cocaine-dependent men were analyzed in this pilot study. Cocaine-dependent subjects (n=12) were compared with cocaine-dependent subjects who also abused or were dependent on cannabis (n=16). After at least 72h of cocaine abstinence, verified using the Timeline Followback and a drug screening test, subjects participated in a functional magnetic resonance imaging session during which neutral and drug cue video sequences were presented. Each sequence comprised four video blocks alternating with resting blocks. We report here subjective craving measures that were collected using the Visual Analog Scale, administered before and after each video block as per standard craving measurement paradigms. Cocaine craving was successfully induced, with no significant difference in cue-induced craving between the two groups. However, post-hoc analyses revealed a significant increase in pre-video cocaine craving scores over time among individuals with cannabis use disorders. We could not highlight significant differences in cocaine craving induction between groups, but we observed a possible deficit in craving decay in the cocaine and cannabis group. In light of this finding, methodology of craving assessment in non-treatment-seeking users, particularly when different substances are combined, should possibly include outcomes linked to craving decay. Studies examining the association between cocaine craving decay and other outcome measures, such as relapse, are also warranted.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002189 Marijuana Abuse Use of marijuana associated with abnormal psychological, social, and or occupational functioning. Cannabis Abuse,Cannabis Dependence,Cannabis-Related Disorder,Hashish Abuse,Marijuana Dependence,Marihuana Abuse,Abuse, Cannabis,Abuse, Hashish,Abuse, Marihuana,Abuse, Marijuana,Cannabis Related Disorder,Dependence, Cannabis,Dependence, Marijuana,Disorder, Cannabis-Related
D003463 Cues Signals for an action; that specific portion of a perceptual field or pattern of stimuli to which a subject has learned to respond. Cue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
June 2011, Experimental and clinical psychopharmacology,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
March 1999, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
June 2022, Drug and alcohol dependence,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
February 2004, The American journal of psychiatry,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
March 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
March 1999, Psychopharmacology,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
January 1999, The American journal of psychiatry,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
March 2007, Alcoholism, clinical and experimental research,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
April 2007, Experimental and clinical psychopharmacology,
K Giasson-Gariépy, and S Potvin, and M Ghabrash, and J Bruneau, and D Jutras-Aswad
July 2003, Clinical EEG (electroencephalography),
Copied contents to your clipboard!